142 related articles for article (PubMed ID: 35196886)
1. Association between amyloid-beta deposition and cortical thickness in dementia with Lewy bodies.
Chin KS; Gajamange S; Desmond PM; Villemagne VL; Rowe CC; Churilov L; Yassi N; Watson R
Aust N Z J Psychiatry; 2023 Apr; 57(4):594-602. PubMed ID: 35196886
[TBL] [Abstract][Full Text] [Related]
2. Tau in dementia with Lewy bodies.
Chin KS; Churilov L; Doré V; Villemagne VL; Rowe CC; Yassi N; Watson R
Aust N Z J Psychiatry; 2024 Feb; 58(2):175-182. PubMed ID: 37264610
[TBL] [Abstract][Full Text] [Related]
3. Beta amyloid deposition maps onto hippocampal and subiculum atrophy in dementia with Lewy bodies.
Mak E; Donaghy PC; McKiernan E; Firbank MJ; Lloyd J; Petrides GS; Thomas AJ; O'Brien JT
Neurobiol Aging; 2019 Jan; 73():74-81. PubMed ID: 30339962
[TBL] [Abstract][Full Text] [Related]
4. Amyloid-β-related and unrelated cortical thinning in dementia with Lewy bodies.
Lee YG; Jeon S; Yoo HS; Chung SJ; Lee SK; Lee PH; Sohn YH; Yun M; Evans AC; Ye BS
Neurobiol Aging; 2018 Dec; 72():32-39. PubMed ID: 30205358
[TBL] [Abstract][Full Text] [Related]
5. Amyloid-β deposition and regional grey matter atrophy rates in dementia with Lewy bodies.
Sarro L; Senjem ML; Lundt ES; Przybelski SA; Lesnick TG; Graff-Radford J; Boeve BF; Lowe VJ; Ferman TJ; Knopman DS; Comi G; Filippi M; Petersen RC; Jack CR; Kantarci K
Brain; 2016 Oct; 139(Pt 10):2740-2750. PubMed ID: 27452602
[TBL] [Abstract][Full Text] [Related]
6. Clinical and imaging correlates of amyloid deposition in dementia with Lewy bodies.
Donaghy PC; Firbank MJ; Thomas AJ; Lloyd J; Petrides G; Barnett N; Olsen K; O'Brien JT
Mov Disord; 2018 Jul; 33(7):1130-1138. PubMed ID: 29672930
[TBL] [Abstract][Full Text] [Related]
7. Differential Vulnerability of Hippocampal Subfields to Amyloid and Tau Deposition in the Lewy Body Diseases.
Ye R; Goodheart AE; Locascio JJ; Peterec E; Properzi M; Thibault EG; Chuba E; Johnson KA; Brickhouse MJ; Touroutoglou A; Growdon JH; Dickerson BC; Gomperts SN
Neurology; 2024 Jun; 102(12):e209460. PubMed ID: 38815233
[TBL] [Abstract][Full Text] [Related]
8. Diffusion imaging in dementia with Lewy bodies: Associations with amyloid burden, atrophy, vascular factors and clinical features.
Donaghy PC; Firbank M; Petrides G; Lloyd J; Barnett N; Olsen K; Thomas AJ; O'Brien JT
Parkinsonism Relat Disord; 2020 Sep; 78():109-115. PubMed ID: 32814228
[TBL] [Abstract][Full Text] [Related]
9. Amyloid PET Imaging in Lewy body disorders.
Donaghy P; Thomas AJ; O'Brien JT
Am J Geriatr Psychiatry; 2015 Jan; 23(1):23-37. PubMed ID: 23831180
[TBL] [Abstract][Full Text] [Related]
10. Cortical thinning in dementia with Lewy bodies and Parkinson disease dementia.
Colloby SJ; Watson R; Blamire AM; O'Brien JT; Taylor JP
Aust N Z J Psychiatry; 2020 Jun; 54(6):633-643. PubMed ID: 31696728
[TBL] [Abstract][Full Text] [Related]
11. Distinct patterns of amyloid-dependent tau accumulation in Lewy body diseases.
Lee SH; Cho H; Choi JY; Lee JH; Ryu YH; Lee MS; Lyoo CH
Mov Disord; 2018 Feb; 33(2):262-272. PubMed ID: 29168583
[TBL] [Abstract][Full Text] [Related]
12. β-Amyloid in Lewy body disease is related to Alzheimer's disease-like atrophy.
Shimada H; Shinotoh H; Hirano S; Miyoshi M; Sato K; Tanaka N; Ota T; Fukushi K; Irie T; Ito H; Higuchi M; Kuwabara S; Suhara T
Mov Disord; 2013 Feb; 28(2):169-75. PubMed ID: 23225334
[TBL] [Abstract][Full Text] [Related]
13. Imaging and acetylcholinesterase inhibitor response in dementia with Lewy bodies.
Graff-Radford J; Boeve BF; Pedraza O; Ferman TJ; Przybelski S; Lesnick TG; Vemuri P; Senjem ML; Smith GE; Knopman DS; Lowe V; Jack CR; Petersen RC; Kantarci K
Brain; 2012 Aug; 135(Pt 8):2470-7. PubMed ID: 22810436
[TBL] [Abstract][Full Text] [Related]
14. Molecular imaging of dementia.
Mori T; Maeda J; Shimada H; Higuchi M; Shinotoh H; Ueno S; Suhara T
Psychogeriatrics; 2012 Jun; 12(2):106-14. PubMed ID: 22712644
[TBL] [Abstract][Full Text] [Related]
15. Topography of cortical thinning in the Lewy body diseases.
Ye R; Touroutoglou A; Brickhouse M; Katz S; Growdon JH; Johnson KA; Dickerson BC; Gomperts SN
Neuroimage Clin; 2020; 26():102196. PubMed ID: 32059167
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of Tau Imaging in Staging Alzheimer Disease and Revealing Interactions Between β-Amyloid and Tauopathy.
Wang L; Benzinger TL; Su Y; Christensen J; Friedrichsen K; Aldea P; McConathy J; Cairns NJ; Fagan AM; Morris JC; Ances BM
JAMA Neurol; 2016 Sep; 73(9):1070-7. PubMed ID: 27454922
[TBL] [Abstract][Full Text] [Related]
17. Cholinergic dysfunction, neurodegeneration, and amyloid-beta pathology in neurodegenerative diseases.
Petrova T; Orellana C; Jelic V; Oeksengaard AR; Snaedal J; Høgh P; Andersen BB; Naik M; Engedal K; Wahlund LO; Ferreira D
Psychiatry Res Neuroimaging; 2020 Aug; 302():111099. PubMed ID: 32505903
[TBL] [Abstract][Full Text] [Related]
18. Amyloid imaging of Lewy body-associated disorders.
Foster ER; Campbell MC; Burack MA; Hartlein J; Flores HP; Cairns NJ; Hershey T; Perlmutter JS
Mov Disord; 2010 Nov; 25(15):2516-23. PubMed ID: 20922808
[TBL] [Abstract][Full Text] [Related]
19. Amyloid Beta-Weighted Cortical Thickness: A New Imaging Biomarker in Alzheimer's Disease.
Kim CM; Hwang J; Lee JM; Roh JH; Lee JH; Koh JY;
Curr Alzheimer Res; 2015; 12(6):563-71. PubMed ID: 26027813
[TBL] [Abstract][Full Text] [Related]
20. The influence of hippocampal atrophy on the cognitive phenotype of dementia with Lewy bodies.
Elder GJ; Mactier K; Colloby SJ; Watson R; Blamire AM; O'Brien JT; Taylor JP
Int J Geriatr Psychiatry; 2017 Nov; 32(11):1182-1189. PubMed ID: 28425185
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
